Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Artery Disease

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Coronary Artery Disease in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.67)18.7374
1990's3 (20.00)18.2507
2000's5 (33.33)29.6817
2010's5 (33.33)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Raheem, SG1
Bennett, SA; Fai, S; Herrmann, N; Lanctôt, KL; Mazereeuw, G; Swardfager, W; Valenzuela, N; Xu, H1
Ayaz, G; Batar, B; Dirican, A; Guven, M; Ilerigelen, B; Kanigur, G; Karadag, B; Onaran, I; Ulutin, T1
Bennett, SA; Figeys, D; Herrmann, N; Lanctôt, KL; Mazereeuw, G; Oh, PI; Xu, H1
Chou, YI; Kong, J; Song, R; Yan, L; Zhang, Y; Zheng, L1
Schneider, DJ; Sobel, BE1
Demopoulos, CA; Kolovou, G; Kolovou, V; Papakonstantinou, VD; Stamatakis, G; Verouti, SN; Xanthopoulou, MN1
Møller, CH; Steinbrüchel, DA1
Bickel, C; Blankenberg, S; Cambien, F; Carrier, JL; Ninio, E; Perret, C; Rupprecht, HJ; Stengel, D; Tiret, L; Tregouet, D1
Backer, CL; Crawford, SE; Huang, L; Huang, X; Mavroudis, C; Mu, Y; Pahl, E; Stellmach, V; Volpert, OV1
Willerson, JT1
Kwiterovich, PO1
Anwar, A; Cohen, JC; Johnston, JM; Shohet, RV1
Macphee, CH1
Gratsianskiĭ, NA; Men'shikov, MIu; Panchenko, EP; Shalaev, SV; Tkachuk, VA1

Reviews

4 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Artery Disease

ArticleYear
Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration.
    Neuroscience and biobehavioral reviews, 2013, Volume: 37, Issue:8

    Topics: Animals; Biomarkers; Blood Platelets; Coronary Artery Disease; Depressive Disorder; Humans; Inflammation; Nerve Degeneration; Oxidative Stress; Platelet Activating Factor; Signal Transduction

2013
Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.
    Texas Heart Institute journal, 1995, Volume: 22, Issue:1

    Topics: Animals; Blood Coagulation Factors; Blood Platelets; Coronary Artery Disease; Coronary Circulation; Coronary Thrombosis; Endothelium, Vascular; Humans; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Vasoconstriction

1995
The antiatherogenic role of high-density lipoprotein cholesterol.
    The American journal of cardiology, 1998, Nov-05, Volume: 82, Issue:9A

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Anticholesteremic Agents; Aryldialkylphosphatase; Biological Transport; Biomarkers; Carrier Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Esterases; Humans; Incidence; Lipoproteins, HDL; Liver; Niacin; Phospholipases A; Platelet Activating Factor; Prognosis; Receptors, Lipoprotein; Risk Factors; RNA-Binding Proteins; Survival Rate

1998
Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target.
    Current opinion in pharmacology, 2001, Volume: 1, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Biomarkers; Coronary Artery Disease; Enzyme Inhibitors; Fatty Acids, Nonesterified; Humans; Infections; Inflammation; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Risk Factors

2001

Other Studies

11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Coronary Artery Disease

ArticleYear
Investigating platelet-activating factor as a potent proinflammatory mediator in coronary atherosclerotic patients.
    Cellular and molecular biology (Noisy-le-Grand, France), 2021, Nov-25, Volume: 67, Issue:3

    Topics: Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Humans; Inflammation Mediators; Lipoproteins, HDL; Male; Middle Aged; Platelet Activating Factor; Risk Factors; Sensitivity and Specificity

2021
The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population.
    Gene, 2013, Sep-15, Volume: 527, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Case-Control Studies; Coronary Artery Disease; Female; Gene Frequency; Genetic Association Studies; Haplotypes; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Activating Factor; Polymorphism, Single Nucleotide; Risk; Turkey

2013
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study.
    Journal of neuroinflammation, 2014, Jul-04, Volume: 11

    Topics: Aged; Chromatography, High Pressure Liquid; Cognition Disorders; Coronary Artery Disease; Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Platelet Activating Factor; Spectrometry, Mass, Electrospray Ionization; Statistics as Topic

2014
Correlations of platelet-derived microparticles with thromboxane B2, platelet-activating factor, endothelin-1, and neutrophil to lymphocyte ratio in patients with coronary intermediate lesions.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2014, Volume: 19, Issue:8

    Topics: Aged; Biomarkers; Blood Platelets; Coronary Artery Disease; Endothelin-1; Female; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Platelet Activating Factor; Platelet Activation; Thromboxane B2

2014
Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation.
    Coronary artery disease, 2009, Volume: 20, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Platelets; Clinical Trials as Topic; Coronary Artery Disease; Crotalid Venoms; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinolytic Agents; Flow Cytometry; Heparin; Hirudins; Humans; Lectins, C-Type; P-Selectin; Peptide Fragments; Peptides; Pilot Projects; Platelet Activating Factor; Platelet Activation; Platelet Function Tests; Recombinant Proteins; Research Design; Thrombin

2009
Platelet activating factor levels and metabolism in Tangier disease: a case study.
    Lipids in health and disease, 2012, Jul-08, Volume: 11

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Adenosine Diphosphate; Adult; Aged; Animals; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biological Assay; Blood Platelets; Coronary Artery Disease; Diacylglycerol Cholinephosphotransferase; Female; Humans; Middle Aged; Mutation; Platelet Activating Factor; Platelet Aggregation; Rabbits; Reference Values; Tangier Disease; Thrombin

2012
Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery?
    Scandinavian cardiovascular journal : SCJ, 2003, Volume: 37, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Loss, Surgical; Blood Platelets; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Female; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Perioperative Care; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Probability; Prospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Rate; Treatment Outcome

2003
Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Human molecular genetics, 2004, Jul-01, Volume: 13, Issue:13

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Genetic Predisposition to Disease; Haplotypes; Humans; Lipoproteins, LDL; Phenotype; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Receptors, G-Protein-Coupled

2004
Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Culture Techniques; Cell Movement; Cornea; Coronary Artery Disease; Disease Models, Animal; Endothelial Cells; Heart Transplantation; Male; Neovascularization, Physiologic; Platelet Activating Factor; Rats; Rats, Inbred F344; Rats, Inbred Lew; Vascular Endothelial Growth Factor A

2004
Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis.
    The American journal of cardiology, 1999, Jan-01, Volume: 83, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Risk Factors

1999
[Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1986, Volume: 9, Issue:2

    Topics: Adenosine Diphosphate; Adult; Angina Pectoris; Blood Platelets; Calcium; Coronary Artery Disease; Coronary Disease; Cytoplasm; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Serotonin

1986